Viral Conjunctivitis Treatment Study

NATerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

February 8, 2020

Study Completion Date

February 8, 2020

Conditions
Viral Conjunctivitis
Interventions
DEVICE

0.01% Hypochlorous acid

Randomized to treatment 0.01% Hypochlorous acid four times a day to the affected eye for 2 weeks. (Avenova is a FDA approved device)

OTHER

Placebo

Placebo to be used four times a day to the affected eye for 2 weeks

Trial Locations (1)

33136

University of Miami Bascom Palmer Eye Institute, Miami

Sponsors
All Listed Sponsors
collaborator

NovaBay Pharmaceuticals, Inc.

INDUSTRY

lead

University of Miami

OTHER

NCT03861728 - Viral Conjunctivitis Treatment Study | Biotech Hunter | Biotech Hunter